Merck KGaA (OTCMKTS:MKKGY - Get Free Report) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 16,700 shares, an increase of 4,075.0% from the December 31st total of 400 shares. Based on an average trading volume of 329,400 shares, the days-to-cover ratio is currently 0.1 days.
Merck KGaA Stock Down 4.3 %
Shares of OTCMKTS MKKGY traded down $1.35 during mid-day trading on Friday, hitting $30.30. 107,771 shares of the stock traded hands, compared to its average volume of 160,312. The company has a market cap of $19.58 billion, a price-to-earnings ratio of 18.70, a PEG ratio of 2.22 and a beta of 0.93. The stock has a fifty day moving average price of $29.57 and a 200-day moving average price of $33.09. Merck KGaA has a 52 week low of $28.29 and a 52 week high of $39.17. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.